Mostrar el registro sencillo del ítem
dc.contributor.author | Buonfrate, D. | |
dc.contributor.author | Angheben, A. | |
dc.contributor.author | Gobbi, F. | |
dc.contributor.author | Muñoz, J. | |
dc.contributor.author | Requena-Mendez, A. | |
dc.contributor.author | Gotuzzo Herencia, José Eduardo | |
dc.contributor.author | Mena, M.A. | |
dc.contributor.author | Bisoffi, Z. | |
dc.date.accessioned | 2022-01-18T19:26:45Z | |
dc.date.available | 2022-01-18T19:26:45Z | |
dc.date.issued | 2012 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/10832 | |
dc.description.abstract | Strongyloidiasis is extremely more frequent in immigrants than in travellers. Clinical presentations do not differ significantly between the two groups, and the most frequent picture is a chronic infection characterized by intermittent, mild, non-specific symptoms. Acute presentation is rare but it has been reported in travellers. Screening of asymptomatic subjects is not generally recommended, while a presumptive treatment with ivermectin might be justified for all travellers and immigrant patients presenting unexplained eosinophilia and/or compatible symptoms, even in case of negative test results. In fact, delayed diagnosis and treatment has life-threatening consequences in patients with conditions predisposing to development of hyperinfection and dissemination. | en_US |
dc.language.iso | eng | |
dc.publisher | Springer | |
dc.relation.ispartofseries | Current Infectious Disease Reports | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | Risk Assessment | en_US |
dc.subject | Disease Association | en_US |
dc.subject | Abdominal Pain | en_US |
dc.subject | Diarrhea | en_US |
dc.subject | Drug Efficacy | en_US |
dc.subject | Drug Megadose | en_US |
dc.subject | Incidence | en_US |
dc.subject | Prevalence | en_US |
dc.subject | Albendazole | en_US |
dc.subject | Eosinophilia | en_US |
dc.subject | Strongyloidiasis | en_US |
dc.subject | Infection Risk | en_US |
dc.subject | Clinical Feature | en_US |
dc.subject | Drug Dose Comparison | en_US |
dc.subject | Dose Response | en_US |
dc.subject | Dyspnea | en_US |
dc.subject | Travel | en_US |
dc.subject | Drug Tolerability | en_US |
dc.subject | Single Drug Dose | en_US |
dc.subject | Coughing | en_US |
dc.subject | Ivermectin | en_US |
dc.subject | Rash | en_US |
dc.subject | Strongyloides Stercoralis | en_US |
dc.subject | Urticaria | en_US |
dc.subject | Immigrants | en_US |
dc.subject | Imported | en_US |
dc.subject | Loeffler Pneumonia | en_US |
dc.subject | Refugee | en_US |
dc.subject | Skin Pruritus | en_US |
dc.subject | Travellers | en_US |
dc.title | Imported strongyloidiasis: Epidemiology, presentations, and treatment | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1007/s11908-012-0248-6 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.03.08 | |
dc.relation.issn | 1534-3146 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |